REGENXBIO Inc.
RGNX· Nasdaq
RGNXREGENXBIO Inc.
Filed Nov 9, 2016 · 10-Q · 40 days after period end · 0001564590-16-028642
| Metric | Q3 2016 | Q3 2015 | Q3 2014 |
|---|---|---|---|
| Revenue | $125.00K | $1.14M | $483.00K |
| Net Income | -$18.15M | -$7.33M | -$1.79M |
| EPS Diluted | -$0.69 | -$1.52 | -$0.73 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
REGENXBIO Inc. · CIK 1590877 · Engraved from SEC EDGAR
ended Sep 30, 2016 · filed Nov 9, 2016 · 40 d after period end
